

CALIFORNICATION: The Spreckels Union School District in Monterey County has agreed to pay a mother $100,000 for socially transitioning her 11-year-old daughter without her knowledge or consent. The girl has since decided to re-identify as the female she is.

CATHOLIC: CLICK https://www.youtube.com/watch?v=au9Bemm6yD0 [6:22] for a quick primer in what the RCC teaches about the Mass and Holy Eucharist.

FINLAND: Finnish lawmaker Päivi Räsänen (63) is on trial this week for violating Finland’s hate speech laws by using Bible verses to express her support for traditional marriage. Along with Räsänen, a Finnish Lutheran bishop named Juhana Pohjola is also being tried for hate speech for publishing a pamphlet written by Räsänen that advocated for the biblical understanding of sexuality and marriage.
Both were unanimously acquitted by a Finnish District Court in 2022, then prosecutors appealed their acquittal to the Helsinki Court of Appeal. The two, who are being represented by the Alliance Defending Freedom International (ADF), face tens of thousands of Euros in fines and possibly two years in prison if they are found guilty. Additionally, the court could also rule to censor Räsänen’s publications.

OMG: CLICK https://www.youtube.com/watch?v=TZ1S7M5Tfcw [20:29] to see James O’Keefe’s report about school board officials who called police because some of the citizens at a meeting looked “Trumpish.” The cop is just as bad. “Get a life.” LOL That is James O’Keefe’s life. ::smh:: The follow up is @ https://www.youtube.com/watch?v=b0Ffb6z8G08 [6:44].

VAXXX: A paper was recently published in the peer-reviewed journal, Clinical Infectious Diseases (Volume 75, Issue 1, 1 July 2022, Pages e545–e551). Entitled “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study,” it reports on a study done by scientists in Israel.
The study was designed to compare long-term protection from symptomatic breakthrough infection conferred by 2 doses of the Pfizer/BioNTech BNT162b2 vaccine (Group 1 = 16, 215 individuals) vs. long-term protection from symptomatic reinfection conferred by naturally-acquired immunity (Group 2 = 46,035 individuals who were never vaccinated).
Participants were all 16 or older and had either had two doses or had recovered from a documented SARS-CoV-2 infection by February 28, 2021. The groups were matched as closely as possible for age, gender, and comorbidities.
At the completion of the study, no one in either group had died from COVID-19. Among the 62,250 individuals in the study, 748 caught SARS-CoV-2; 640 from Group 1 vs. 108 from Group 2. Eight of the Group 1 cases needed hospitalizations vs. none of the Group 2 cases. After adjusting for comorbidities, researchers calculated that the vaccinated group were about 6 times more likely than the naturally immune to get sick.







